Anales de la RANM

172 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 DATOS Y ALGORITMOS QUE CURAN Dopazo J An RANM. 2026;143(02): 167 - 173 AGRADECIMIENTOS El autor agradece a los miembros y colaboradores de las distintas líneas de investigación que han contribuido al desarrollo de los modelos mecanís- ticos, las herramientas computacionales y los casos de aplicación discutidos en este artículo, así como a las instituciones y agencias financiadoras que han apoyado estos trabajos como el ISCIII (PMP24/00024, IMP/00019, COV20/00788), el Ministerio de Ciencia, Innovación (PID2023- 152380OB, TED2021-132346B-I00, PID2020- 117979RB-I00), la Consejería de Salud y familias, junta de Andalucía (IE19_259 FPS, P18-RT-3471 ) y Fundación BBVA (G999088Q). DECLARACIÓN DE TRANSPARENCIA El autor/a de este artículo declara no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. BIBLIOGRAFÍA 1. Altucci L, Badimon L, Balligand JL, et al. Arti- ficial Intelligence and Network Medicine: Path to Precision Medicine. NEJM AI. 2025;2(9). https://doi.org/10.1056/AIRA2401229. 2. Wang H, Arulraj T, Ippolito A, Popel AS. From virtual patients to digital twins in immuno- oncology: lessons learned from mechanistic quantitative systems pharmacology modeling. npj Digital Medicine 2024 7:1. 2024;7(1): 189-. https://doi.org/10.1038/s41746-024-01188-4. 3. De Domenico M, Allegri L, Caldarelli G, et al. Challenges and opportunities for digital tw- ins in precision medicine from a complex sys- tems perspective. npj Digital Medicine 2025 8:1. 2025;8(1): 37-. https://doi.org/10.1038/ s41746-024-01402-3. 4. Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy- based analysis of pathways and genomes. Nu- cleic Acids Research. 2023;51(D1): D587–D592. https://doi.org/10.1093/NAR/GKAC963. 5. Ragueneau E, Gong C, Sinquin P, et al. The Reactome Knowledgebase 2026. Nucleic Acids Research. 2026;54(D1): D673–D681. https:// doi.org/10.1093/NAR/GKAF1223. 6. Ostaszewski M, Niarakis A, Mazei, et al. CO- VID19 Disease Map, a computational knowled- ge repository of virus–host interaction mecha- nisms. Molecular Systems Biology 2021 17:10. 2021;17(10): MSB202110387-. https://doi. org/10.15252/MSB.202110387. 7. Agrawal A, Balcı H, Hanspers K, et al. Wiki- Pathways 2024: next generation pathway da- tabase. Nucleic Acids Research. 2024;52(D1): D679–D689. https://doi.org/10.1093/NAR/ GKAD960. 8. Peña-Chilet M, Esteban-Medina M, Falco MM, et al. Using mechanistic models for the clinical interpretation of complex geno- mic variation. Scientific Reports 2019 9:1. 2019;9(1): 18937-. https://doi.org/10.1038/ s41598-019-55454-7. 9. Rian K, Hidalgo MR, Çubuk C, et al. Geno- me-scale mechanistic modeling of signaling pathways made easy: A bioconductor/cytos- cape/web server framework for the analysis of omic data. Computational and Structural Biotechnology Journal. 2021;19: 2968–2978. https://doi.org/10.1016/J.CSBJ.2021.05.022; 10. Amadoz A, Hidalgo MR, Çubuk C, Car- bonell-Caballero J, Dopazo J. A compa- rison of mechanistic signaling pathway activity analysis methods. Briefings in Bioin- formatics. 2019;20(5): 1655–1668. https://doi. org/10.1093/BIB/BBY040. 11. Hidalgo MR, Cubuk C, Amadoz A, et al. High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes. On- cotarget. 2016;8(3): 5160–5178. https://doi. org/10.18632/ONCOTARGET.14107. 12. Crespo Márquez A. The Curse of Dimensiona- lity. Springer Series in Reliability Engineering. 2022; 67–86. https://doi.org/10.1007/978-3- 030-97660-6_7/SAVE-RESEARCH 13. Loucera C, Esteban-Medina M, Rian K, Falco MM, Dopazo J, Peña-Chilet M. Drug repur- posing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection. Sig- nal Transduction and Targeted Therapy 2020 5:1. 2020;5(1): 290-. https://doi.org/10.1038/ s41392-020-00417-y 14. Muñoyerro-Muñiz D, Villegas R, de la Oliva V, et al. Ethical and secure evidence genera- tion from regionwide clinical data through a collaborative environment for advancing predictive care. Frontiers in Public Health. 2025;13: 1630351. https://doi.org/10.3389/ fpubh.2025.1630351 15. Hanahan D. Hallmarks of Cancer: New Di- mensions. Cancer Discovery. 2022;12(1): 31– 46. https://doi.org/10.1158/2159-8290.CD-21- 1059 16. Strausberg RL, Buetow KH, Emmert-Buck MR, Klausner RD. The Cancer Genome Anatomy Project: Building an annotated gene index. Trends in Genetics. 2000;16(3): 103–106. https://doi.org/10.1016/S0168- 9525(99)01937-X. 17. Hidalgo MR, Amadoz A, Çubuk C, Carbonell- Caballero J, Dopazo J. Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome. Biology Direct 2018 13:1. 2018;13(1): 16-. https://doi.org/10.1186/S13062-018-0219-4 18. Cubuk C, Hidalgo MR, Amadoz A, et al. Gene expression integration into pathway modu- les reveals a pan-cancer metabolic landscape. Cancer Research. 2018;78(21): 6059–6072. https://doi.org/10.1158/0008-5472.CAN-17- 2705/653103/AM/GENE-EXPRESSION-IN- TEGRATION-INTO-PATHWAY-MODULES